Atlas Trials

Autologous Bulbar Olfactory Ensheathing Cells and Nerve Grafts for Treatment of Patients With Spinal Cord Transection

Clinical trial NCT03933072 · UNKNOWN

Trial details

NCT number
NCT03933072
Sponsor
Nicholls Spinal Injury Foundation
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Spinal Cord Injury at C5-Th10 Level With Complete LesionSpinal Cord Transection
Start date
2016-03-01
Primary completion
2023-03-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.